We are live on
!
Find out more
EAM
Erste Asset Management Portfolio holdings
AUM
$12.9B
1-Year Est. Return
52.69%
This Fund
S&P 500
This Quarter
Est. Return
+17.19%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
–
AUM
$2.26B
AUM Growth
+$384M
(+20%)
Cap. Flow
+$115M
Cap. Flow
% of AUM
5.09%
Top 10 Holdings %
Top 10 Hldgs %
22.4%
Holding
443
New
33
Increased
160
Reduced
64
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$39.7M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$14.6M |
| 3 |
Agios Pharmaceuticals
AGIO
|
+$10.1M |
| 4 |
Westlake Corp
WLK
|
+$8.6M |
| 5 |
Booking.com
BKNG
|
+$6.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$26.3M |
| 2 |
CELG
Celgene Corp
CELG
|
+$20.8M |
| 3 |
TIF
Tiffany & Co.
TIF
|
+$8.44M |
| 4 |
iShares Semiconductor ETF
SOXX
|
+$7.14M |
| 5 |
Roper Technologies
ROP
|
+$5.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.75% |
| 2 | Technology | 20.83% |
| 3 | Consumer Discretionary | 14.53% |
| 4 | Financials | 9.34% |
| 5 | Miscellaneous | 6.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
iShares Global Tech ETF
IXN
$9.18B
| $105K | ﹤0.01% |
3,000
| – | – |
|
352
Ambev
ABEV
$46.6B
| $102K | ﹤0.01% |
22,000
| – | – |
|
353
Baidu
BIDU
$30.9B
| $88.5K | ﹤0.01% |
700
| – | – |
|
354
Trimble
TRMB
$13.7B
| $83.9K | ﹤0.01% |
2,000
| – | – |
|
355
Franco-Nevada
FNV
$50.7B
| $82.7K | ﹤0.01% |
800
| – | – |
|
|
JOYY
356
JOYY Inc
JOYY
$3.78B
| $82K | ﹤0.01% |
1,500
| – | – |
|
357
Altria Group
MO
$117B
| $79.3K | ﹤0.01% |
1,590
-2,975
| -65% | -$140K |
|
358
Fortinet
FTNT
$126B
| $74.9K | ﹤0.01% |
3,500
-51,500
| -94% | -$969K |
|
359
Takeda Pharmaceutical
TAK
$59.7B
| $72.5K | ﹤0.01% |
3,674
| – | – |
|
360
Jones Lang LaSalle
JLL
$15.7B
| $63.9K | ﹤0.01% |
367
+77
| +27% | +$12.1K |
|
361
Walmart Inc
WMT
$858B
| $60.9K | ﹤0.01% |
1,530
-639
| -29% | -$25.4K |
|
362
Freeport-McMoran
FCX
$99.6B
| $59.8K | ﹤0.01% |
4,600
| – | – |
|
363
Ralph Lauren
RL
$20B
| $58.6K | ﹤0.01% |
500
| – | – |
|
364
FMC
FMC
$1.41B
| $57.3K | ﹤0.01% |
578
+384
| +198% | +$35.7K |
|
365
Hamilton Lane
HLNE
$5.13B
| $41.5K | ﹤0.01% |
685
+355
| +108% | +$20.5K |
|
|
OTIC
366
DELISTED
Otonomy, Inc.
OTIC
| $35.5K | ﹤0.01% |
11,700
| – | – |
|
|
JWN
367
DELISTED
Nordstrom
JWN
| $24.6K | ﹤0.01% |
600
| – | – |
|
368
Tesla
TSLA
$1.41T
| $23.6K | ﹤0.01% |
855
| – | – |
|
369
Nutanix
NTNX
$18.4B
| $17.5K | ﹤0.01% |
570
| – | – |
|
370
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.87B
| $15.4K | ﹤0.01% |
210
| – | – |
|
371
Berkshire Hathaway Class B
BRK.B
$1.11T
| $14.8K | ﹤0.01% |
65
-549
| -89% | -$119K |
|
372
Gold Fields
GFI
$38.2B
| $14.6K | ﹤0.01% |
2,200
| – | – |
|
373
GE Aerospace
GE
$319B
| $11.1K | ﹤0.01% |
201
-29,101
| -99% | -$1.5M |
|
374
Boeing
BA
$166B
| $10.4K | ﹤0.01% |
+32
| New | +$11.3K |
|
|
GCVRZ
375
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $10.3K | ﹤0.01% |
12,000
| – | – |
|
Similar funds
FFA
GKIM
WI
CRM
PCM
BCI
VLKIM
BAMF
Erste Asset Management's Q4 2019 Portfolio in Review
As of Q4 2019, Erste Asset Management held 443 positions worth $2.26B, up 20% from $1.88B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Erste Asset Management deployed $115M of net new capital in Q4 2019, opening 33 new positions and adding to 160 existing holdings. Its largest new stake was Westlake Corp: 128,000 shares worth $8.83M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $26.3M trimmed.
- Erste Asset Management's largest Q4 2019 buy was Westlake Corp: 128,000 shares worth $8.83M.
- Erste Asset Management added most to Biogen in Q4 2019, an estimated $39.7M increase.
- Erste Asset Management's biggest Q4 2019 reduction was Vertex Pharmaceuticals, cutting an estimated $26.3M.
- Erste Asset Management fully exited Celgene Corp in Q4 2019, selling an estimated $20.8M.
- Erste Asset Management's ten largest holdings make up 22% of its $2.26B portfolio in Q4 2019.
- Erste Asset Management opened 33 new positions and closed 38 in Q4 2019.
- Erste Asset Management's portfolio value rose 20% quarter-over-quarter to $2.26B.
Based on Erste Asset Management's 13F filing for Q4 2019, filed 22 Nov 2024.